A detailed history of Xponance, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Xponance, Inc. holds 10,309 shares of INSM stock, worth $754,103. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,309
Previous 9,827 4.9%
Holding current value
$754,103
Previous $658,000 14.29%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$62.0 - $79.01 $29,884 - $38,082
482 Added 4.9%
10,309 $752,000
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $32,054 - $101,567
1,457 Added 17.41%
9,827 $658,000
Q1 2024

May 13, 2024

BUY
$25.72 - $29.94 $540 - $628
21 Added 0.25%
8,370 $227,000
Q4 2023

Jan 31, 2024

BUY
$23.42 - $31.74 $195,533 - $264,997
8,349 New
8,349 $258,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.91B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.